Loading clinical trials...

Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE) | Clinical Trials | Clareo Health

UNKNOWNNA

Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)

Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE): Open Multicentric Randomized Study for Evaluation of Outcomes, Complications, and Health Economics

NCT05531240•Uppsala University

View on ClinicalTrials.gov

Summary

This study focuses on the treatment of benign prostatic hyperplasia which causes lower urinary tract symptoms. The purpose of the research project is to evaluate PAE in terms of both medical and health economic outcomes. To evaluate whether there are any differences in effect (IPSS), complications, costs and perceived quality of life compared with TUR-P.

Eligibility

Age

45 - No limit years

Sex

MALE

Healthy Volunteers

Inclusion Criteria

•Benign prostatic hyperplasia where medical treatment has not helped or for other reasons has not been deemed applicable
•IPSS\>=8
•Prostate volume \[40-80\] ml measured via transrectal ultrasound
•Peak flow rate (Qmax) \<= 15 ml / s,
•Verified obstruction by urodynamic studies (cystometry)
•Surgery not contraindicated

Exclusion Criteria

•Prostate cancer
•Severe atherosclerosis
•Kidney failure
•Urethral stricture
•Active cystitis or prostatitis
•Bladder stone.
•Neurogenic bladder disorder
•Contrast product allergy

Locations (4)

Helsingborgs Hospital

Helsingborg, Region Skånes, Sweden

Mälarsjukhuset

Eskilstuna, Region Sörmland, Sweden

Lasarettet i Enköping

Enköping, Region Uppsala, Sweden

Region Vastmanland Hospital

Västerås, Västmanland County, Sweden

Key Dates

Start Date

October 1, 2022

Primary Completion Date

December 1, 2023

Completion Date

December 1, 2025

Last Updated

October 3, 2022

Enrollment

104

ESTIMATED participants

Conditions

Transurethral Resection of Prostate SyndromeProstate HyperplasiaEmbolization, Therapeutic

Interventions

Prostate Artery Embolization

PROCEDURE

Transurethral Prostate Resection (TURP)

PROCEDURE

Contacts

Emir Majbar, MD

CONTACT

+4621173000 emir.majbar@regionvastmanland.se

Farhood Alamdari, MD, PhD

CONTACT

+4621173000 farhood.alamdari@regionvastmanland.se

Prostate Metabolism, Cancer Risk and Gut Microbiota

NCT06116851

Prostate CancerProstate Hyperplasia

View study

COMPLETEDNA

Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH

NCT05440981

Prostate Hyperplasia

View study

COMPLETEDPHASE4

Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 3, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)

Inclusion Criteria

Exclusion Criteria

Prostate Metabolism, Cancer Risk and Gut Microbiota

Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH

Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)

Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia

Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics

MRI Guided Transrectal Prostate Laser Ablation for Benign Prostatic Hypertrophy (BPH)